InnoCan Pharma (OTC:INNPF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does InnoCan Pharma (INNPF) operate in?

InnoCan Pharma is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

InnoCan Pharma Stock (OTC: INNPF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 2.93K
Day Range	- - -
52 Wk Range	0.14 - 0.35
Market Cap	$51.08M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	2.86

Recent News

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark

Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.

Patricio Liddle

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration (FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move, the company initiated the regulatory process with the FDA for the approval of its prolonged CBD release technology for human use.

Jelena Martinovic

534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations

Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strategic vision.

Patricio Liddle

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy InnoCan Pharma (INNPF) stock?

You can purchase shares of InnoCan Pharma (OTCQB:INNPF) through any online brokerage.

View our list of the best stock brokerages

Who are InnoCan Pharma (INNPF) competitors?

There are no as such competitors for InnoCan Pharma.

What is the target price for InnoCan Pharma (INNPF) stock?

There is no analysis for InnoCan Pharma.

What is the forecast for InnoCan Pharma (INNPF) stock?

There is no analysis for InnoCan Pharma to provide a consensus price target.

Current stock price for InnoCan Pharma (INNPF)?

The stock price for InnoCan Pharma (OTCQB: INNPF) is $0.182 last updated July 2, 2024 at 1:06 PM EDT.

Does InnoCan Pharma (INNPF) pay a dividend?

There are no upcoming dividends for InnoCan Pharma.

When is InnoCan Pharma (OTCQB:INNPF) reporting earnings?

InnoCan Pharma does not have any upcoming earnings scheduled.

Is InnoCan Pharma (INNPF) going to split?

There is no upcoming split for InnoCan Pharma.

What sector and industry does InnoCan Pharma (INNPF) operate in?

InnoCan Pharma is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

InnoCan Pharma

InnoCan Pharma (INNPF) Forecast